Form D · Biotechnology
Terrestrial Bio, Inc.
Woburn, MA · CIK 0001578117
Offering snapshot reported Mar 19, 2026 · SEC filing
- Reported sold
- $57.3M Offering amount: $83.5M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 4, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2026 | Initial | $57,301,758 | No comparison | 16 | SEC filing |
| Sep 10, 2025 | Initial | $7,903,411 | No comparison | 4 | SEC filing |
| Feb 26, 2025 | Initial | $8,400,000 | No comparison | 3 | SEC filing |
| May 28, 2024 | Initial | $10,775,983 | No comparison | 6 | SEC filing |
| Jul 24, 2023 | Initial | $9,096,986 | No comparison | 4 | SEC filing |
| Dec 23, 2022 | Amendment | $35,012,500 | $9,712,500vs May 14, 2021 | 7 | SEC filing |
| Oct 4, 2022 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| May 14, 2021 | Initial | $25,300,000 | No comparison | 7 | SEC filing |
| Mar 26, 2021 | Initial | $2,000,000 | No comparison | 3 | SEC filing |
| Feb 15, 2019 | Initial | $3,575,000 | No comparison | 4 | SEC filing |
| Jan 9, 2017 | Initial | $862,857 | No comparison | 2 | SEC filing |
| May 29, 2013 | Initial | $1,250,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-577032
Amounts include conversion of certain outstanding convertible securities. A portion of the Total Remaining to be Sold is reserved to be sold upon a future milestone closing.
Source: Form D, filed Mar 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mario Barro | Director |
| James Connolly | Director |
| Ann De Witt | Director |
| Matthew Dirckx | Executive |
| Fenel Eloi | Director |
| Johannes Fruehauf | Director |
| Ted Hibben | Executive |
| Shuenn Ho | Executive |
| Jonathan Kluge | Executive |
| Peter Kolchinsky | Director |
| Kathryn Kosuda | Director, Executive |
| Kathryn Kousda | Director, Executive |
| Fiorenzo Omenetto | Director |
| Aaron Sandoski | Director |
| Purnanand Sarma | Director |
| Michael Schrader | Director, Executive |
| Rachel Sha | Director, Executive |
| John Spiridigliozzi | Executive |
| Weiner Tilsner | Executive |
| Mark Tracy | Executive |
| Lynda Tussey | Executive |
| Linda Tussey | Executive |
| Livio Valenti | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
30 Cummings Park Drive
Woburn, MA, 01801
Woburn, MA, 01801